Genital Human Papillomavirus (HPV) infection is the most common sexually transmitted infection; most sexually active women acquire HPV at some point in their lives. HR-HPV types are the cause of almost all cervical cancers.
Meridian is currently conducting a research study for an investigational HPV vaccine.
- Must be a female age 16 to 26
- Must not have had previous vaccination against HPV
- Must not have a history of positive HPV test or external genital/vaginal warts
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you or your child.
You can also talk to a Meridian enrollment specialist about this study by calling (712) 639-6200.
Submit your information
Meridian Clinical Research
3400 W Norfolk Avenue
Norfolk, NE 68701
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.